NCT05797623: Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia |
|
|
| Recruiting | 2 | 78 | RoW | Trappa ethanolamine tablets ; ciclosporin, Placebo ; ciclosporin | Jiangsu HengRui Medicine Co., Ltd. | Non-severe Aplastic Anemia | 05/24 | 05/25 | | |
NCT01623167: Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia |
|
|
| Recruiting | 1/2 | 207 | US | Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Horse Antithymocyte Globulin, Cyclosporine, Promacta, Eltrombopag, Cohort 2: hATG, CsA, EPAG Day 14 to Month 3, Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6, Extension Cohort, Horse Antithymocyte Globulin (hATG), Cyclosporine (CsA), Promacta, Eltrombopag (EPAG) | National Heart, Lung, and Blood Institute (NHLBI), Novartis | Severe Aplastic Anemia | 01/18 | 01/29 | | |
